ES2061307T3 - Empleo del principio activo azelastina y eteres de glicerol para combatir enfermedades psoriasicas. - Google Patents

Empleo del principio activo azelastina y eteres de glicerol para combatir enfermedades psoriasicas.

Info

Publication number
ES2061307T3
ES2061307T3 ES92119073T ES92119073T ES2061307T3 ES 2061307 T3 ES2061307 T3 ES 2061307T3 ES 92119073 T ES92119073 T ES 92119073T ES 92119073 T ES92119073 T ES 92119073T ES 2061307 T3 ES2061307 T3 ES 2061307T3
Authority
ES
Spain
Prior art keywords
psoriasic
combat
diseases
active substance
glycerol ethers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92119073T
Other languages
English (en)
Inventor
Jurgen Dr Engel
Michael Dr Molliere
Istvan Dr Szelenyi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asta Medica GmbH
Original Assignee
Asta Medica GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica GmbH filed Critical Asta Medica GmbH
Application granted granted Critical
Publication of ES2061307T3 publication Critical patent/ES2061307T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • E—FIXED CONSTRUCTIONS
    • E02—HYDRAULIC ENGINEERING; FOUNDATIONS; SOIL SHIFTING
    • E02F—DREDGING; SOIL-SHIFTING
    • E02F3/00—Dredgers; Soil-shifting machines
    • E02F3/04—Dredgers; Soil-shifting machines mechanically-driven
    • E02F3/18—Dredgers; Soil-shifting machines mechanically-driven with digging wheels turning round an axis, e.g. bucket-type wheels
    • E02F3/20—Dredgers; Soil-shifting machines mechanically-driven with digging wheels turning round an axis, e.g. bucket-type wheels with tools that only loosen the material, i.e. mill-type wheels
    • E02F3/205—Dredgers; Soil-shifting machines mechanically-driven with digging wheels turning round an axis, e.g. bucket-type wheels with tools that only loosen the material, i.e. mill-type wheels with a pair of digging wheels, e.g. slotting machines
    • E—FIXED CONSTRUCTIONS
    • E02—HYDRAULIC ENGINEERING; FOUNDATIONS; SOIL SHIFTING
    • E02F—DREDGING; SOIL-SHIFTING
    • E02F3/00—Dredgers; Soil-shifting machines
    • E02F3/04—Dredgers; Soil-shifting machines mechanically-driven
    • E02F3/88—Dredgers; Soil-shifting machines mechanically-driven with arrangements acting by a sucking or forcing effect, e.g. suction dredgers
    • E02F3/90—Component parts, e.g. arrangement or adaptation of pumps
    • E—FIXED CONSTRUCTIONS
    • E02—HYDRAULIC ENGINEERING; FOUNDATIONS; SOIL SHIFTING
    • E02F—DREDGING; SOIL-SHIFTING
    • E02F3/00—Dredgers; Soil-shifting machines
    • E02F3/04—Dredgers; Soil-shifting machines mechanically-driven
    • E02F3/88—Dredgers; Soil-shifting machines mechanically-driven with arrangements acting by a sucking or forcing effect, e.g. suction dredgers
    • E02F3/90—Component parts, e.g. arrangement or adaptation of pumps
    • E02F3/92—Digging elements, e.g. suction heads
    • E02F3/9212—Mechanical digging means, e.g. suction wheels, i.e. wheel with a suction inlet attached behind the wheel

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mining & Mineral Resources (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Structural Engineering (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Civil Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

APLICACION DE AZELASTINA O SUS SALES UTILIZABLES TERAPEUTICAMENTE Y ETERES DE GLICERINA PARA LA PRODUCCION DE UN PREPARADO FARMACEUTICO PARA COMBATIR LAS ENFERMEDADES INFAMATORIAS Y LA PSORIASIS.
ES92119073T 1989-01-11 1990-01-03 Empleo del principio activo azelastina y eteres de glicerol para combatir enfermedades psoriasicas. Expired - Lifetime ES2061307T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3900607 1989-01-11

Publications (1)

Publication Number Publication Date
ES2061307T3 true ES2061307T3 (es) 1994-12-01

Family

ID=6371863

Family Applications (2)

Application Number Title Priority Date Filing Date
ES90100071T Expired - Lifetime ES2063841T3 (es) 1989-01-11 1990-01-03 Utilizacion del principio activo azelastin para combatir enfermedades de la psoriasis.
ES92119073T Expired - Lifetime ES2061307T3 (es) 1989-01-11 1990-01-03 Empleo del principio activo azelastina y eteres de glicerol para combatir enfermedades psoriasicas.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES90100071T Expired - Lifetime ES2063841T3 (es) 1989-01-11 1990-01-03 Utilizacion del principio activo azelastin para combatir enfermedades de la psoriasis.

Country Status (15)

Country Link
US (1) US5110814A (es)
EP (2) EP0378086B1 (es)
JP (1) JP2991733B2 (es)
AT (2) ATE113208T1 (es)
AU (1) AU618443B2 (es)
CA (1) CA2007480C (es)
DE (3) DE59007288D1 (es)
DK (2) DK0378086T3 (es)
EG (1) EG19912A (es)
ES (2) ES2063841T3 (es)
HK (2) HK50495A (es)
IE (1) IE65336B1 (es)
MC (1) MC2078A1 (es)
PT (1) PT92821B (es)
SG (2) SG30593G (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3190441B2 (ja) * 1992-07-20 2001-07-23 エーザイ株式会社 塩酸アゼラスチンを含有する安定な製剤
NL9201438A (nl) * 1992-08-11 1994-03-01 Prospa Bv Nieuwe farmaceutische samenstellingen die esters van omega-3 polyonverzadigde zuren omvatten en de toepassing ervan bij de plaatselijke behandeling van ziekelijke aandoeningen.
CZ199593A3 (en) * 1992-10-02 1994-04-13 Asta Medica Ag Phthalazinone derivatives exhibiting anti-arrhythmic and analgesic activity and eliminating resistance to a plurality of medicaments (mdr)
US5569680A (en) * 1995-02-13 1996-10-29 Trustees Of The Univ. Of Penna Method of treating inflammatory bowel disease with tributyrin
JP4138910B2 (ja) * 1997-07-02 2008-08-27 帝國製薬株式会社 経皮吸収性が良好で且つ皮膚刺激性の少ない塩酸アゼラスチン含有経皮製剤
US6984667B2 (en) * 1998-04-08 2006-01-10 Theta Biomedical Consulting And Development Co. Synergistic proteoglycan compositions for inflammatory conditions
DE19826517B4 (de) * 1998-06-15 2006-03-23 Baxter Healthcare S.A. Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette
DE10028638A1 (de) 2000-06-09 2001-12-20 Schuelke & Mayr Gmbh Lagerstabile Zusammensetzungen von Glycerinmonoalkylethern
BRPI0415557A (pt) * 2003-10-31 2006-12-26 Hexal Ag formulação contendo ingrediente ativo farmacêutico com revestimento
WO2005077963A1 (fr) * 2004-01-16 2005-08-25 Institut Superieur Agricole De Beauvais DErivEs de saccharides et d'itols possEdant un groupement O-alkyle ou un groupement O-alkyle et un groupement O-n-butanoyle. Applications comme mEdicaments dans les pathologies prolifEratives tumorales ou bEnignes.
US20070020330A1 (en) * 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
PL2486942T3 (pl) * 2004-11-24 2019-05-31 Meda Pharmaceuticals Inc Kompozycje zawierające azelastynę oraz sposoby ich stosowania
EP2968323A4 (en) 2013-03-13 2016-12-14 Flatley Discovery Lab PYRIDAZINONE COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS
US10835584B2 (en) * 2016-06-17 2020-11-17 Nuvothera, Inc. Systems for treating dermal inflammatory conditions
US11389458B2 (en) 2019-04-12 2022-07-19 LA PharmaTech Inc. Pharmaceutical compositions and methods for treating parkinson's and huntington's disease
US11744833B2 (en) 2019-04-12 2023-09-05 LA PharmaTech Inc. Pharmaceutical compositions and methods for treatment of insomnia
US11690849B2 (en) 2019-04-12 2023-07-04 LA PharmaTech Inc. Method of treating dementia
US11938139B2 (en) * 2019-04-12 2024-03-26 LA PharmaTech Inc. Pharmaceutical compositions and methods for anxiety, depression and other psychiatric disorders
US11318144B2 (en) 2019-04-12 2022-05-03 LA PharmaTech Inc. Compositions and methods for treating Alzheimer's disease and Parkinson's disease
US10966989B2 (en) 2019-04-12 2021-04-06 LA PharmaTech Inc. Pharmaceutical compositions and methods for treating mental, behavioral, cognitive disorders
US10639314B1 (en) 2019-04-30 2020-05-05 LA PharmaTech Inc. Method of treating Alzheimer's disease
JP7498551B2 (ja) * 2019-09-26 2024-06-12 株式会社Adeka 抗炎症剤
US11351179B1 (en) 2021-08-05 2022-06-07 LA PharmaTech Inc. Pharmaceutical compositions and methods for treatment of psychiatric disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3840606A (en) * 1969-12-05 1974-10-08 Oreal Process of producing mono and polyhydroxyl ethers
CH572914A5 (es) * 1971-01-22 1976-02-27 Asta Werke Ag Chem Fab
DE3343530A1 (de) * 1983-12-01 1985-06-13 Max Planck Gesellschaft Arzneimittel mit verbesserter penetration der gewebsmembran
US4871733A (en) * 1984-04-09 1989-10-03 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs

Also Published As

Publication number Publication date
AU4786290A (en) 1990-07-19
ATE111735T1 (de) 1994-10-15
IE65336B1 (en) 1995-10-18
IE900098L (en) 1990-07-11
CA2007480C (en) 1995-08-15
DE59007288D1 (de) 1994-10-27
DE4000070A1 (de) 1990-07-12
EP0378086A2 (de) 1990-07-18
CA2007480A1 (en) 1990-07-17
JPH02288827A (ja) 1990-11-28
HK50595A (en) 1995-04-13
ES2063841T3 (es) 1995-01-16
SG30591G (en) 1995-09-18
DK0378086T3 (da) 1994-12-12
EP0533213A1 (de) 1993-03-24
SG30593G (en) 1995-09-18
MC2078A1 (fr) 1991-01-07
US5110814A (en) 1992-05-05
JP2991733B2 (ja) 1999-12-20
EG19912A (en) 1996-05-31
ATE113208T1 (de) 1994-11-15
HK50495A (en) 1995-04-13
EP0378086A3 (de) 1991-02-06
EP0378086B1 (de) 1994-10-26
PT92821A (pt) 1990-07-31
DE59007531D1 (de) 1994-12-01
DK0533213T3 (da) 1994-10-17
EP0533213B1 (de) 1994-09-21
AU618443B2 (en) 1991-12-19
PT92821B (pt) 1995-12-29

Similar Documents

Publication Publication Date Title
ES2063841T3 (es) Utilizacion del principio activo azelastin para combatir enfermedades de la psoriasis.
AR229022A1 (es) Procedimiento para la elaboracion de derivados del alcohol 1-alfa-(n-(carbamoil-hidroxi-fenoxi)-alquilenaminometil-arilico
BR8007609A (pt) Extrator cirurgico para extirpar corpos estranhos atraves das vias naturais do corpo humano
ES2139132T3 (es) Composiciones farmaceuticas activas en la terapia de desordenes del sueño.
NO157020C (no) AnalogifremgangsmŸte ved fremstilling av terapeutisk aktive 3,20-dioxo-1,4-pregnadien-17alfa-ol-17-aromatiske heterocykliske carboxylater.
MX148240A (es) Una composicion detergente desodorante para el aseo del cuerpo humano
IT1148801B (it) Derivati del nor-tropano, loro procedimento di preparazione e loro applicazione terapeutica
IT8848491A0 (it) Impiego in terapeutica di derivati del 4h-benzo-4,5-cicloepta-1,2-bqti ofene
SE7905593L (sv) Acylderivat av karnitin och forfarande for framstellning derav
NO157817C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive glycinamidderivater.
ES435273A1 (es) Un procedimiento de preparacion de n-(1-bencil-pirrolidi- nil-2-alcohil) -benzamidas sustituidas.
ES2037808T3 (es) Procedimiento para la obtencion de medicamentos para la profilaxis y terapia de enfermedades producidas por retrovirus.
SE8304408L (sv) Desoxiuridinderivat, forfaranden for deras framstellning och deras anvendning som lekemedel
MX6053E (es) Procedimiento microbiologico para la preparacion de derivados del sesquiterpeno
IT1151009B (it) Derivati del 5h-furanone-2 e del 3h-diidrofuranone-2,loro procedimento di preparazione e loro applicazione terapeutica
IT7821773A0 (it) Endoscopio per l'esame di cavita'del corpo e per l'esecuzione di coagulazioni.
ES2044170T3 (es) Sal de estroncio, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen.
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
IT7822027A0 (it) Apparecchio medicale per la cura della trombosi venale profonda.
IT1159101B (it) Procedimento per il trattamento del la colibacillosi neonatale e relativo composto farmaceutico
AR220548A1 (es) Procedimiento para la preparacion de una heterovacuna para el tratamiento terapeutico del sindrome de trichomonas
IT7826263A0 (it) Derivati del piranocromone e composizione terapeutica comprendente gli stessi, per il trattamento di malattie allergiche.
SE7701441L (sv) Nytt piperazinyluracilsalt
ES495831A0 (es) Procedimiento para la obtencion de esteres 4,5-dialquil-3- hidroxi-pirrol-2-carboxilicos
IT1102304B (it) Composizione farmaceutica per la cura della sordita' e del ronzio auricolare

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 533213

Country of ref document: ES